ADC Therapeutics SA

NYSE:ADCT

3.1 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Omzet 17.4118.05316.7914.49319.28318.99269.79876.32117.29146.49817.0113.1473.76051.9000001.9621.170.2580.2580.3130.313
Kosten van de omzet 2.0553.3531.2150.3661.3190.590.4891.2952.2660.5290.770.5020.1210.57825.9532.15525.9535.37530.42430.54121.7623.28629.0929.0929.95329.953
Brutowinst 15.35514.715.57514.12717.96418.40269.30975.02615.02545.96916.2412.6453.639-0.57825.95-32.155-25.95-35.375-30.424-30.541-19.798-22.116-28.833-28.833-29.641-29.641
Brutowinstmarge 0.8820.8140.9280.9750.9320.9690.9930.9830.8690.9890.9550.9620.96800.500000-10.091-18.903-111.971-111.971-94.85-94.85
Onderzoek- en ontwikkelingskosten 24.29525.73530.33128.4431.94439.4848.73341.67648.53748.95242.49236.80539.53339.17248.55232.15525.9535.37530.42430.54121.7623.28629.0929.0930.06730.067
Algemene en administratieve kosten 16.08917.60917.21215.05612.59915.14315.13836.46435.89919.01117.92633.63219.36717.58220.09620.27318.9995.8824.922.3024.0893.2962.452.451.9351.935
Verkoop- en marketingkosten 4.855.8129.2828.0358.32915.35116.1768.2369.25918.3718.60317.04515.22113.9119.3536.1164.0042.6280000-0.05-0.050.050.05
Verkoop-, algemene en administratieve kosten 20.10122.57825.22223.09112.59930.49431.31436.46435.89937.38136.52933.63234.58831.49329.44920.27318.9998.514.922.3024.0893.2962.42.41.9851.985
Overige kosten 2.230.2633.7770.6830.2961.412-1.27511.8380.1140.00815.929-7.1462.10421.3630.14334.013-80.7020.1480.2221.433000000
Bedrijfskosten 44.39648.31355.55351.53157.75369.97480.04778.1484.43686.33379.02170.43774.12170.66578.00152.42844.94943.88535.73232.84325.8493.332.3712.3712.022.02
Bedrijfsresultaat -29.041-33.613-39.978-37.404-39.789-51.572-10.7386.867-69.411-40.364-62.781-57.792-70.482-70.665-78.001-52.428-44.949-43.885-35.732-32.843-23.887-25.412-31.232-31.232-31.625-31.625
Bedrijfsresultaat ratio -1.668-1.862-2.381-2.581-2.063-2.715-0.1540.09-4.014-0.868-3.691-4.396-18.7450-1.50300000-12.175-21.72-121.289-121.289-101.2-101.2
Totaal overige inkomsten en kosten netto -6.992-12.390.106-0.687-0.453-8.116-9.452-58.1864.0922.53315.929-9.3630.69321.2324.14533.874-80.8020.1770.3951.0730.010.5830.6360.6360.7850.785
Inkomen voor belasting -36.033-46.003-39.872-47.893-53.727-59.688-20.19-51.319-65.321-17.831-56.352-71.404-72.329-51.42-55.803-20.331-126.453-43.376-35.17-31.073-23.254-24.83-30.596-30.596-30.84-30.84
Inkomen voor belasting ratio -2.07-2.548-2.375-3.305-2.786-3.143-0.289-0.672-3.778-0.383-3.313-5.431-19.2360-1.07500000-11.852-21.222-118.819-118.819-98.688-98.688
Belastingkosten -0.086-0.08443.171-0.086-6.61-0.2623.967-0.711-0.947-1.17-21.9710.1450.240.1070.126-0.0030.1040.10.1150.2680.0940.10.0380.0380.0740.074
Nettowinst -36.544-46.606-85.031-47.807-47.117-59.426-24.157-50.608-64.374-16.661-34.381-71.549-72.569-51.527-55.929-20.328-126.557-43.476-35.285-31.341-23.348-24.929-30.634-30.634-30.914-30.914
Nettowinstmarge -2.099-2.582-5.064-3.299-2.443-3.129-0.346-0.663-3.723-0.358-2.021-5.442-19.30-1.07800000-11.9-21.307-118.967-118.967-98.925-98.925
WPA (Winst Per Aandeel) -0.38-0.56-1.03-0.58-0.58-0.74-0.3-0.65-0.84-0.22-0.45-0.93-0.95-0.67-0.73-0.29-2.01-0.68-0.48-0.43-0.32-0.53-3.08-0.569-0.574-0.574
Verwaterde WPA -0.38-0.56-1.03-0.58-0.58-0.74-0.3-0.65-0.84-0.22-0.45-0.93-0.95-0.67-0.73-0.29-2.01-0.68-0.48-0.43-0.32-0.53-3.08-0.569-0.574-0.574
EBITDA -28.203-32.77-25.368-34.197-37.119-48.525-10.3867.439-70.612-23.956-46.832-66.474-68.897-49.236-53.39-17.763-125.019-42.92-34.795-30.327-23.228-25.278-30.848-31.1-31.513-31.513
EBITDA ratio -1.62-1.815-1.511-2.36-1.925-2.555-0.1490.097-4.084-0.515-2.753-5.056-18.3240-1.02900000-11.839-21.605-119.798-120.777-100.842-100.842